Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.5 USD | +0.63% | +0.23% | -2.31% |
26/04 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
26/04 | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
Chart calendar Abbott Laboratories
Upcoming events on Abbott Laboratories
Past events on Abbott Laboratories
26/04/2024 07:30 pm | Annual General Meeting |
17/04/2024 06:30 pm | Q1 2024 Earnings Call |
17/04/2024 05:00 pm | Q1 2024 Earnings Release |
12/04/2024 | Ex-dividend day |
24/01/2024 07:30 pm | Q4 2023 Earnings Call |
24/01/2024 06:00 pm | Q4 2023 Earnings Release |
11/01/2024 | Ex-dividend day |
09/01/2024 10:30 pm | JPMorgan Healthcare Conference |
18/10/2023 06:30 pm | Q3 2023 Earnings Call |
18/10/2023 05:00 pm | Q3 2023 Earnings Release |
12/10/2023 | Ex-dividend day |
20/07/2023 07:00 pm | Q2 2023 Earnings Call |
20/07/2023 05:00 pm | Q2 2023 Earnings Release |
13/07/2023 | Ex-dividend day |
28/04/2023 07:30 pm | Annual General Meeting |
19/04/2023 06:30 pm | Q1 2023 Earnings Call |
19/04/2023 05:00 pm | Q1 2023 Earnings Release |
13/04/2023 | Ex-dividend day |
25/02/2023 | Cardiovascular Research Technologies Meeting |
25/01/2023 07:30 pm | FY 2022 Earnings Call |
Past dividends on Abbott Laboratories
12/04/2024 | Quarterly 0.55 USD |
11/01/2024 | Quarterly 0.55 USD |
12/10/2023 | Quarterly 0.51 USD |
13/07/2023 | Quarterly 0.51 USD |
13/04/2023 | Quarterly 0.51 USD |
12/01/2023 | Quarterly 0.51 USD |
13/10/2022 | Quarterly 0.47 USD |
14/07/2022 | Quarterly 0.47 USD |
13/04/2022 | Quarterly 0.47 USD |
13/01/2022 | Quarterly 0.47 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 31 904 31 846 0.18% | 34 608 33 854 2.23% | 43 075 42 206 2.06% | 43 653 43 239 0.96% | 40 109 40 077 0.08% | 41 704 |
EBITDA Million USD | Released Forecast Spread | 8 188 8 266 -0.94% | 9 204 8 954 2.79% | 12 815 12 584 1.83% | 12 485 12 337 1.2% | 10 188 10 191 -0.03% | 10 734 |
EBIT Million USD | Released Forecast Spread | 7 110 7 149 -0.55% | 8 009 7 841 2.15% | 11 324 11 010 2.85% | 11 231 11 036 1.77% | 8 911 8 883 0.32% | 9 326 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4 077 3 920 4.01% | 4 968 4 052 22.61% | 8 211 7 728 6.25% | 8 306 8 009 3.71% | 6 664 6 563 1.54% | 6 798 |
Net income Million USD | Released Forecast Spread | 3 687 3 655 0.87% | 4 471 4 415 1.27% | 7 071 6 738 4.94% | 6 933 6 899 0.49% | 5 723 5 652 1.26% | 5 962 |
EPS USD | Released Forecast Spread | 2,06 2,10 -1.69% | 2,49 2,45 1.68% | 3,94 3,80 3.8% | 3,91 3,91 -0% | 3,26 3,23 0.81% | 3,43 |
Announcement Date | 22/01/20 | 27/01/21 | 26/01/22 | 25/01/23 | 24/01/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 11 468 10 697 7.21% | 11 895 10 996 8.17% | 11 257 10 400 8.24% | 10 410 9 650 7.87% | 10 091 9 723 3.78% | 9 747 9 649 1.02% | 9 978 9 715 2.7% | 10 143 9 818 3.31% | 10 241 10 185 0.55% | 9 964 9 876 0.89% | 10 367 | 10 565 | 10 794 | 10 636 |
EBITDA Million USD | Released Forecast Spread | 3 263 2 954 10.46% | 4 247 3 434 23.68% | 3 300 2 762 19.47% | 2 812 2 314 21.52% | 2 442 2 267 7.74% | 2 372 2 328 1.91% | 2 467 2 418 2.04% | 2 606 2 521 3.38% | 2 743 2 700 1.58% | 2 274 | 2 583 | 2 780 | 3 047 | 2 680 |
EBIT Million USD | Released Forecast Spread | 2 894 2 598 11.4% | 3 620 3 058 18.39% | 2 985 2 394 24.71% | 2 495 1 971 26.56% | 2 131 1 958 8.83% | 2 057 2 009 2.41% | 2 165 2 097 3.24% | 2 278 2 200 3.53% | 2 411 2 384 1.14% | 1 959 1 941 0.92% | 2 239 | 2 431 | 2 698 | 2 255 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 562 2 010 -22.29% | 1 636 1 501 8.99% | 1 671 1 611 3.72% | 1 795 1 782 0.73% | 1 436 1 362 5.43% | 1 671 | 1 830 | 2 103 | 1 777 | |||||
Net income Million USD | Released Forecast Spread | 1 989 1 555 27.95% | 2 447 2 277 7.48% | 2 018 1 433 40.87% | 1 435 1 128 27.19% | 1 033 1 032 0.11% | 1 318 1 196 10.16% | 1 375 1 437 -4.35% | 1 436 1 393 3.1% | 1 594 1 522 4.71% | 1 225 1 143 7.15% | 1 394 | 1 565 | 1 824 | 1 577 |
EPS USD | Released Forecast Spread | 1,11 0,89 24.15% | 1,37 1,22 11.95% | 1,14 0,79 44.36% | 0,81 0,64 26.52% | 0,59 0,60 -0.87% | 0,75 0,67 11.29% | 0,78 0,76 2.96% | 0,82 0,79 3.56% | 0,91 0,87 4.89% | 0,70 0,66 6.22% | 0,81 | 0,90 | 1,05 | 0,85 |
Announcement Date | 26/01/22 | 20/04/22 | 20/07/22 | 19/10/22 | 25/01/23 | 19/04/23 | 20/07/23 | 18/10/23 | 24/01/24 | 17/04/24 | - | - | - | - |
Past sector events for Abbott Laboratories
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABT Stock
- Calendar Abbott Laboratories